SimplyRich’s Janux Therapeutics JANX Stock Holding History

SimplyRich’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373K	Hold	24,315	–	–	0.09%	148
2026 Q1	$337K	Hold	24,315	–	–	0.09%	189
2025 Q4	$335K	Hold	24,315	–	–	0.09%	165
2025 Q3	$594K	Hold	24,315	–	–	0.16%	121
2025 Q2	$561K	Hold	24,315	–	–	0.16%	130
2025 Q1	$656K	Hold	24,315	–	–	0.19%	105
2024 Q4	$1.3M	Buy	24,315 +16,351	+205%	+$865K	0.37%	70
2024 Q3	$361K	Hold	7,964	–	–	0.1%	161
2024 Q2	$333K	Hold	7,964	–	–	0.11%	138
2024 Q1	$300K	Buy	+7,964	New	+$173K	0.1%	149

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

SimplyRich's JANX Position: Q2 2026 in Review

SimplyRich held its Janux Therapeutics (JANX) position steady in Q2 2026 at 24,315 shares worth $373K. The position accounts for 0.09% of the portfolio, ranked #148.

SimplyRich first reported a position in JANX in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.3M in Q4 2024. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

SimplyRich held 24,315 shares of Janux Therapeutics worth $373K as of Q2 2026.
SimplyRich left its Janux Therapeutics share count unchanged in Q2 2026.
Janux Therapeutics made up 0.09% of SimplyRich's portfolio in Q2 2026, its #148 holding.
SimplyRich first reported a position in Janux Therapeutics in Q1 2024 and has held it in 10 quarters since.
SimplyRich's Janux Therapeutics position peaked at $1.3M in Q4 2024.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on SimplyRich's 13F filing for Q2 2026, filed 3 Aug 2026.